A new bisuracil analogue, 3,3-bis(uracil-1-yl)-propan-1-aminium (1), together with four known N-containing metabolites (2-5), were isolated from the South China Sea sponge Agelas clathrodes. Their chemical structures were established on the basis of spectroscopic and spectrometric analysis and comparison with known compounds. Compound 1 is an unusual naturally occurring bisuracil analogue, and compound 2 was isolated from a natural source for the first time. Compounds 2 and 4 exhibit moderate cytotoxicity against cancer cell line SGC7901.
Marine sponges of the genus Agelas (order Agelasida, family Agelasidae) have provided a wide variety of natural products, such as glycosphingolipids [1a,b] , bromopyrrole alkaloids [1c,d] and 9-N-methyladeninium diterpenoids [2a-c] . A. clathrodes (Schmidt, 1870) was reported to possess the N-containing metabolites, clathrodin [3a] , clathramides [3b], (-)-agelasidine A [3c], and dispacamides [3d,e] . As part of an ongoing investigation, studies on A. clathrodes led to the isolation of a new bisuracilyl-substituted analogue, 3,3-bis(uracil-1-yl)-propan-1-aminium (1), along with four known compounds (2-5) (Figure 1 H COSY spectrum only showed correlation between H-5 (H-5') (δ H 5.44) and H-6 (H-6') (δ H 7.38). In the HMBC spectrum, the signal of H-5 correlated with those of C-4 and C-6, and HMBC cross-peaks of H-6 with C-2, C-4 and C-5 were also found. The HMBC correlation from the methine proton H-7 (δ H 3.42) to C-6, as well as the downfield chemical shift of C-7 (δ C 72.4) suggested that the uracil moieties were connected to C-7. In addition, the signal of H-7 further correlated with C-9. The downfield chemical shift of C-9 (δ C 63.1) can be explained by the proximity of the aminium [3g]. On the basis of the foregoing analysis, compound 1 was determined as 3,3-bis(uracil-1-yl)-propan-1-aminium. 
Extraction and isolation:
A. clathrodes (240 g, wet weight) was extracted with acetone, CH 2 Cl 2 , and MeOH (500 mL × 2 each) exhaustively at room temperature. The combined extracts were concentrated under reduced pressure to give a brown gum, which was partitioned between CH 2 Cl 2 and H 2 O to afford 2.1 g CH 2 Cl 2 phase extract. This was subjected to CC on Sephadex LH-20 with CH 2 Cl 2 /MeOH (1:1) as eluting solvent to afford 3 fractions (Fr. A-C). Fr. A (670 mg) was subjected to CC on YMC ODS-A (50 µm) to give 6 subfractions (Fr. A1−Fr. A6). Fr. A1 (382.3 mg) was further purified by HPLC (Waters 1525/2996, Symmetry Prep C18, 7 µm, 1.5 mL/min, UV detection at 260 nm) using 10% MeOH/H 2 O as eluent to yield compounds 1 (1.6 mg, t R = 14.5 min) and 3 (20.5 mg, t R = 28.9 min). Fr. A5 (89.6 mg) was separated by HPLC (Waters 1525/2996, Symmetry Prep C18, 7 µm, 60% MeOH/H 2 O, 1.5 mL/min, UV detection at 275 nm) to yield compound 4 (13.6 mg, t R = 43.4 min). Fr. A6 (30.4 mg) was purified by HPLC (Waters 1525/2996, Symmetry Prep C18, 7 µm, 60% CH 3 CN/H 2 O, 1.5 mL/min, UV detection at 275 nm) to afford compound 5 (10.7 mg，t R = 27.1 min). Similarly, Fr. B (170 mg) was subjected to chromatography repeatedly on Sephadex LH-20 and YMC ODS-A, and further purified by HPLC (Waters 1525/2996, SunFire Silica, 5 µm, 1.5 mL/min, UV detection at 210 and 280 nm) eluting with n-hexane/isopropanol (95:5) to give compound 2 (3.7 mg, t R =21.9 min). (uracil-1-yl)-propan-1-aminium (1 Cytotoxicity assay: Cytotoxicity was evaluated as IC 50 by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with 5-fluorouracil as positive control. Compounds 1-5 were solubilized in DMSO with the working concentration of test substances ranging from 1 to 100 µg/mL. Cells were inoculated into 96-well plates. After incubation for 24 h, the cells were treated with various concentrations of test substances for 48 h and then incubated with 1 mg/mL MTT at 37°C for 4 h, followed by solubilization in DMSO. The formazan dye products were measured by the absorbance at 490 nm on a microplate reader.
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